GrantExec

Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)

The URGenT network grant aims to speed up the development and clinical testing of gene-based therapies for ultra-rare neurological or neuromuscular disorders, with the ultimate goal of initiating a clinical trial.

Contact for amount
Closed
Nationwide
Key Dates

Next Deadline

September 11, 2024

Letter of Intent

Application Opens

November 9, 2021

Application Closes

October 11, 2024

Contact Information

Grantor

NIH OER Webmaster

Subscribe to view contact details

Newsletter Required
Categories
Health